|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. International journal of cancer. J Int Cancer.
127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Kaatsch P, Spix C, Katalinic A, Hentschel
S, Luttmann S and Stegmaier C: Cancer in Germany 2011/2012. Robert
Koch Institute and the Society of Epidemiological Cancer Registries
in Germany. Robert-Koch-Institut; Berlin: 2015, (In German).
|
|
3
|
Licitra L, Zigon G, Gatta G, Sanchez MJ
and Berrino F: Human papillomavirus in HNSCC: A European
epidemiologic perspective. Hematol Oncol Clin North Am.
22:1143–1153, vii-viii. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chaturvedi AK, Engels EA, Anderson WF and
Gillison ML: Incidence trends for human papillomavirus-related and
-unrelated oral squamous cell carcinomas in the United States. J
Clin Oncol. 26:612–619. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Syrjänen KJ, Pyrhönen S, Syrjänen SM and
Lamberg MA: Immunohistochemical demonstration of human papilloma
virus (HPV) antigens in oral squamous cell lesions. Br J Oral Surg.
21:147–153. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
World Health Organization; International
Agency for Research on Cancer: Human Papillomaviruses. IARc
Monographs on the Evaluation of Carcinogenic Risks to Humans. 90.
IARC; Lyon: pp. 1–636. 2007, PubMed/NCBI
|
|
7
|
Chaturvedi AK, Engels EA, Pfeiffer RM,
Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M,
Cozen W, et al: Human papillomavirus and rising oropharyngeal
cancer incidence in the United States. J Clin Oncol. 29:4294–4301.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mehanna H, Beech T, Nicholson T, El-Hariry
I, McConkey C, Paleri V and Roberts S: Prevalence of human
papillomavirus in oropharyngeal and nonoropharyngeal head and neck
cancer-systematic review and meta-analysis of trends by time and
region. Head Neck. 35:747–755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stein AP, Saha S, Yu M, Kimple RJ and
Lambert PF: Prevalence of human papillomavirus in oropharyngeal
squamous cell carcinoma in the United States across time. Chem Res
Toxicol. 27:462–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liberati A, Altman DG, Tetzlaff J, Mulrow
C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J
and Moher D: The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate health care
interventions: Explanation and elaboration. PLoS Med.
6:e10001002009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moher D1, Liberati A, Tetzlaff J and
Altman DG; PRISMA Group, . Preferred reporting items for systematic
reviews and meta-analyses: the PRISMA statement. Ann Intern Med.
151:264–269. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Al-Swiahb JN, Huang CC, Fang FM, Chuang
HC, Huang HY, Luo SD, Chen CH, Chen CM and Chien CY: Prognostic
impact of p16, p53, epidermal growth factor receptor, and human
papillomavirus in oropharyngeal cancer in a betel nut-chewing area.
Arch Otolaryngol Head Neck Surg. 136:502–508. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baumeister P, Reiter M, Welz C, Becker S,
Betz C and Harréus U: Surgically treated oropharyngeal cancer: Risk
factors and tumor characteristics. J Cancer Res Clin Oncol.
140:1011–1019. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bledsoe TJ, Noble AR, Hunter GK, Rybicki
LA, Hoschar A, Chute DJ, Saxton JP, Greskovich JF, Adelstein DJ and
Koyfman SA: Oropharyngeal squamous cell carcinoma with known human
papillomavirus status treated with definitive chemoradiotherapy:
Patterns of failure and toxicity outcomes. Radiat Oncol. 8:1742013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bossi P, Orlandi E, Miceli R, Perrone F,
Guzzo M, Mariani L, Granata R, Locati L, Fallai C, Cortelazzi B,
Pilotti S, et al: Treatment-related outcome of oropharyngeal cancer
patients differentiated by HPV dictated risk profile: a tertiary
cancer centre series analysis. Ann Oncol. 25:694–699. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Broglie MA, Soltermann A, Rohrbach D,
Haile SR, Pawlita M, Studer G, Huber GF, Moch H and Stoeckli SJ:
Impact of p16, p53, smoking, and alcohol on survival in patients
with oropharyngeal squamous cell carcinoma treated with primary
intensity-modulated chemoradiation. Head Neck. 35:1698–1706. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bussu F, Sali M, Gallus R, Petrone G,
Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Vellone VG,
Graziani C, et al: Human papillomavirus (HPV) infection in squamous
cell carcinomas arising from the oropharynx: Detection of HPV DNA
and p16 immunohistochemistry as diagnostic and prognostic
indicators-a pilot study. Int J Radiat Oncol Biol Phys.
89:1115–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cerezo L, López C, de la Torre A, Suárez
D, Hervás A, Ruiz A, Ballestín C, Martín M and Sandoval P:
Incidence of human papillomavirus-related oropharyngeal cancer and
outcomes after chemoradiation in a population of heavy smokers.
Head Neck. 36:782–786. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Charfi L, Jouffroy T, de Cremoux P, Le
Peltier N, Thioux M, Fréneaux P, Point D, Girod A, Rodriguez J and
Sastre-Garau X: Two types of squamous cell carcinoma of the
palatine tonsil characterized by distinct etiology, molecular
features and outcome. Cancer Lett. 260:72–78. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chernock RD, Zhang Q, El-Mofty SK,
Thorstad WL and Lewis JS Jr: Human papillomavirus-related squamous
cell carcinoma of the oropharynx: A comparative study in whites and
African Americans. Arch Otolaryngol Head Neck Surg. 137:163–169.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chien CY, Su CY, Fang FM, Huang HY, Chuang
HC, Chen CM and Huang CC: Lower prevalence but favorable survival
for human papillomavirus-related squamous cell carcinoma of tonsil
in Taiwan. Oral Oncol. 44:174–179. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cohen MA, Weinstein GS, O'Malley BW Jr,
Feldman M and Quon H: Transoral robotic surgery and human
papillomavirus status: Oncologic results. Head Neck. 33:573–580.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
D'Souza G, Kreimer AR, Viscidi R, Pawlita
M, Fakhry C, Koch WM, Westra WH and Gillison ML: Case-control study
of human papillomavirus and oropharyngeal cancer. N Engl J Med.
356:1944–1956. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ernster JA, Sciotto CG, O'Brien MM, Finch
JL, Robinson LJ, Willson T and Mathews M: Rising incidence of
oropharyngeal cancer and the role of oncogenic human papilloma
virus. Laryngoscope. 117:2115–2128. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Evans M, Newcombe R, Fiander A, Powell J,
Rolles M, Thavaraj S, Robinson M and Powell N: Human
Papillomavirus-associated oropharyngeal cancer: An observational
study of diagnosis, prevalence and prognosis in a UK population.
BMC Cancer. 13:2202013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fakhry C, Zhang Q, Nguyen-Tan PF,
Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A,
Avizonis V, Ridge JA, et al: Human papillomavirus and overall
survival after progression of oropharyngeal squamous cell
carcinoma. J Clin Oncol. 32:3365–3373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fallai C, Perrone F, Licitra L, Pilotti S,
Locati L, Bossi P, Orlandi E, Palazzi M and Olmi P: Oropharyngeal
squamous cell carcinoma treated with radiotherapy or
radiochemotherapy: Prognostic role of TP53 and HPV status. Int J
Radiat Oncol Biol Phys. 75:1053–1059. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fei J, Hong A, Dobbins TA, Jones D, Lee
CS, Loo C, Al-Ghamdi M, Harnett GB, Clark J, O'Brien CJ, et al:
Prognostic significance of vascular endothelial growth factor in
squamous cell carcinomas of the tonsil in relation to human
papillomavirus status and epidermal growth factor receptor. Ann
Surg Oncol. 16:2908–2917. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fischer CA, Kampmann M, Zlobec I, Green E,
Tornillo L, Lugli A, Wolfensberger M and Terracciano LM: p16
expression in oropharyngeal cancer: its impact on staging and
prognosis compared with the conventional clinical staging
parameters. Ann Oncol. 21:1961–1966. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Geiger JL, Lazim AF, Walsh FJ, Foote RL,
Moore EJ, Okuno SH, Olsen KD, Kasperbauer JL, Price DL, Garces YI,
et al: Adjuvant chemoradiation therapy with high-dose versus weekly
cisplatin for resected, locally-advanced HPV/p16-positive and
negative head and neck squamous cell carcinoma. Oral Oncol.
50:311–318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gillison ML, Zhang Q, Jordan R, Xiao W,
Westra WH, Trotti A, Spencer S, Harris J, Chung CH and Ang KK:
Tobacco smoking and increased risk of death and progression for
patients with p16-positive and p16-negative oropharyngeal cancer. J
Clin Oncol. 30:2102–2111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hafkamp HC, Manni JJ, Haesevoets A, Voogd
AC, Schepers M, Bot FJ, Hopman AH, Ramaekers FC and Speel EJ:
Marked differences in survival rate between smokers and nonsmokers
with HPV 16-associated tonsillar carcinomas. Int J Cancer.
122:2656–2664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hama T, Tokumaru Y, Fujii M, Yane K, Okami
K, Kato K, Masuda M, Mineta H, Nakashima T, Sugasawa M, et al:
Prevalence of human papillomavirus in oropharyngeal cancer: A
multicenter study in Japan. Oncology. 87:173–182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hannisdal K, Schjølberg A, De Angelis PM,
Boysen M and Clausen OP: Human papillomavirus (HPV)-positive
tonsillar carcinomas are frequent and have a favourable prognosis
in males in Norway. Acta Otolaryngol. 130:293–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hong A, Dobbins T, Lee CS, Jones D,
Jackson E, Clark J, Armstrong B, Harnett G, Milross C, O'Brien C
and Rose B: Relationships between epidermal growth factor receptor
expression and human papillomavirus status as markers of prognosis
in oropharyngeal cancer. Eur J Cancer. 46:2088–2096. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hong AM, Dobbins TA, Lee CS, Jones D,
Harnett GB, Armstrong BK, Clark JR, Milross CG, Kim J, O'Brien CJ,
et al: Human papillomavirus predicts outcome in oropharyngeal
cancer in patients treated primarily with surgery or radiation
therapy. Br J Cancer. 103:1510–1517. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang H, Zhang B, Chen W, Zhou SM, Zhang
YX, Gao L, Xu ZG, Qiao YL and Tang PZ: Human papillomavirus
infection and prognostic predictors in patients with oropharyngeal
squamous cell carcinoma. Asian Pac J Cancer Prev. 13:891–896. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Isayeva T, Xu J, Dai Q, Whitley AC, Bonner
J, Nabell L, Spencer S, Carroll W, Jones G, Ragin C, et al: African
Americans with oropharyngeal carcinoma have significantly poorer
outcomes despite similar rates of human papillomavirus-mediated
carcinogenesis. Hum Pathol. 45:310–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Joo YH, Cho KJ, Park JO, Nam IC and Kim
MS: Factors influencing the outcomes of primary surgery with
postoperative radiotherapy for pN2 oropharyneal squamous cell
carcinoma. Oral Oncol. 48:90–94. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jung AC, Briolat J, Millon R, de Reyniès
A, Rickman D, Thomas E, Abecassis J, Clavel C and Wasylyk B:
Biological and clinical relevance of transcriptionally active human
papillomavirus (HPV) infection in oropharynx squamous cell
carcinoma. International journal of cancer. Int J Cancer.
126:1882–1894. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Junor E, Kerr G, Oniscu A, Campbell S,
Kouzeli I, Gourley C and Cuschieri K: Benefit of chemotherapy as
part of treatment for HPV DNA-positive but p16-negative squamous
cell carcinoma of the oropharynx. Br J Cancer. 106:358–365. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kawakami H, Okamoto I, Terao K, Sakai K,
Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, et al: Human
papillomavirus DNA and p16 expression in Japanese patients with
oropharyngeal squamous cell carcinoma. Cancer Med. 2:933–941. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Klussmann JP, Mooren JJ, Lehnen M,
Claessen SM, Stenner M, Huebbers CU, Weissenborn SJ, Wedemeyer I,
Preuss SF, Straetmans JM and Manni JJ: Genetic signatures of
HPV-related and unrelated oropharyngeal carcinoma and their
prognostic implications. Clin Cancer Res. 15:1779–1786. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH
and Lin MC: The biomarkers of human papillomavirus infection in
tonsillar squamous cell carcinoma-molecular basis and predicting
favorable outcome. Mod Pathol. 21:376–386. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lewis JS Jr, Thorstad WL, Chernock RD,
Haughey BH, Yip JH, Zhang Q and El-Mofty SK: p16 positive
oropharyngeal squamous cell carcinoma:an entity with a favorable
prognosis regardless of tumor HPV status. Am J Surg Pathol.
34:1088–1096. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li W, Thompson CH, O'Brien CJ, McNeil EB,
Scolyer RA, Cossart YE, Veness MJ, Walker DM, Morgan GJ and Rose
BR: Human papillomavirus positivity predicts favourable outcome for
squamous carcinoma of the tonsil. International journal of cancer.
Int J Cancer. 106:553–558. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Licitra L, Perrone F, Bossi P, Suardi S,
Mariani L, Artusi R, Oggionni M, Rossini C, Cantù G, Squadrelli M,
et al: High-risk human papillomavirus affects prognosis in patients
with surgically treated oropharyngeal squamous cell carcinoma. J
Clin Oncol. 24:5630–5636. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin BM, Wang H, D'Souza G, Zhang Z, Fakhry
C, Joseph AW, Drake VE, Sanguineti G, Westra WH and Pai SI:
Long-term prognosis and risk factors among patients with
HPV-associated oropharyngeal squamous cell carcinoma. Cancer.
119:3462–3471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lindquist D, Ahrlund-Richter A, Tarján M,
Tot T and Dalianis T: Intense CD44 expression is a negative
prognostic factor in tonsillar and base of tongue cancer.
Anticancer Res. 32:153–161. 2012.PubMed/NCBI
|
|
51
|
Lindquist D, Romanitan M, Hammarstedt L,
Näsman A, Dahlstrand H, Lindholm J, Onelöv L, Ramqvist T, Ye W,
Munck-Wikland E, et al: Human papillomavirus is a favourable
prognostic factor in tonsillar cancer and its oncogenic role is
supported by the expression of E6 and E7. Mol Oncol. 1:350–355.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ljøkjel B, Lybak S, Haave H, Olofsson J,
Vintermyr OK and Aarstad HJ: The impact of HPV infection on
survival in a geographically defined cohort of oropharynx squamous
cell carcinoma (OPSCC) patients in whom surgical treatment has been
one main treatment. Acta Otolaryngol. 134:636–645. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Marklund L, Näsman A, Ramqvist T, Dalianis
T, Munck-Wikland E and Hammarstedt L: Prevalence of human
papillomavirus and survival in oropharyngeal cancer other than
tonsil or base of tongue cancer. Cancer Med. 1:82–88. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Maxwell JH, Kumar B, Feng FY, Worden FP,
Lee JS, Eisbruch A, Wolf GT, Prince ME, Moyer JS, Teknos TN,
Chepeha DB, et al: Tobacco use in human papillomavirus-positive
advanced oropharynx cancer patients related to increased risk of
distant metastases and tumor recurrence. Clin Cancer Res.
16:1226–1235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Melkane AE, Auperin A, Saulnier P, Lacroix
L, Vielh P, Casiraghi O, Msakni I, Drusch F and Temam S: Human
papillomavirus prevalence and prognostic implication in
oropharyngeal squamous cell carcinomas. Head Neck. 36:257–265.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mizumachi T, Kano S, Sakashita T,
Hatakeyama H, Suzuki S, Homma A, Oridate N and Fukuda S: Improved
survival of Japanese patients with human papillomavirus-positive
oropharyngeal squamous cell carcinoma. Int J Clin Oncol.
18:824–828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Näsman A, Nordfors C, Grün N,
Munck-Wikland E, Ramqvist T, Marklund L, Lindquist D and Dalianis
T: Absent/weak CD44 intensity and positive human papillomavirus
(HPV) status in oropharyngeal squamous cell carcinoma indicates a
very high survival. Cancer Med. 2:507–518. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Nichols AC, Dhaliwal SS, Palma DA, Basmaji
J, Chapeskie C, Dowthwaite S, Franklin JH, Fung K, Kwan K, Wehrli
B, et al: Does HPV type affect outcome in oropharyngeal cancer? J
Otolaryngol Head Neck Surg. 42(9)2013.
|
|
59
|
Nichols AC, Palma DA, Dhaliwal SS, Tan S,
Theuer J, Chow W, Rajakumar C, Um S, Mundi N, Berk S, et al: The
epidemic of human papillomavirus and oropharyngeal cancer in a
Canadian population. Curr Oncol. 20:212–219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Nichols AC, Finkelstein DM, Faquin WC,
Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM,
Clark JR and Rocco JW: Bcl2 and human papilloma virus 16 as
predictors of outcome following concurrent chemoradiation for
advanced oropharyngeal cancer. Clin Cancer Res. 16:2138–2146. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
O'Sullivan B, Huang SH, Perez-Ordonez B,
Massey C, Siu LL, Weinreb I, Hope A, Kim J, Bayley AJ, Cummings B,
et al: Outcomes of HPV-related oropharyngeal cancer patients
treated by radiotherapy alone using altered fractionation.
Radiother Oncol. 103:49–56. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
O'Sullivan B, Huang SH, Siu LL, Waldron J,
Zhao H, Perez-Ordonez B, Weinreb I, Kim J, Ringash J, Bayley A, et
al: Deintensification candidate subgroups in human
papillomavirus-related oropharyngeal cancer according to minimal
risk of distant metastasis. J Clin Oncol. 31:543–550. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Oguejiofor KK, Hall JS, Mani N, Douglas C,
Slevin NJ, Homer J, Hall G and West CM: The prognostic significance
of the biomarker p16 in oropharyngeal squamous cell carcinoma. Clin
Oncol (R Coll Radiol). 25:630–638. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Park K, Cho KJ, Lee M, Yoon DH, Kim J, Kim
SY, Nam SY, Choi SH, Roh JL, Han MW, et al: p16
immunohistochemistry alone is a better prognosticator in tonsil
cancer than human papillomavirus in situ hybridization with or
without p16 immunohistochemistry. Acta Otolaryngol. 133:297–304.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Park WS, Ryu J, Cho KH, Choi MK, Moon SH,
Yun T, Chun BS, Lee GK, Ahn HJ, Lee JH, et al: Human papillomavirus
in oropharyngeal squamous cell carcinomas in Korea: Use of G1 cycle
markers as new prognosticators. Head Neck. 34:1408–1417. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Posner MR, Lorch JH, Goloubeva O, Tan M,
Schumaker LM, Sarlis NJ, Haddad RI and Cullen KJ: Survival and
human papillomavirus in oropharynx cancer in TAX 324: a subset
analysis from an international phase III trial. Ann Oncol.
22:1071–1077. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Psychogios G, Alexiou C, Agaimy A, Brunner
K, Koch M, Mantsopoulos K, Tomppert A and Iro H: Epidemiology and
survival of HPV-related tonsillar carcinoma. Cancer Med. 3:652–659.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Psychogios G, Mantsopoulos K, Agaimy A,
Koch M, Zenk J, Waldfahrer F and Iro H: Prognostic factors in
limited (T1-2, N0-1) oropharyngeal carcinoma treated with surgery ±
adjuvant therapy. Head Neck. 35:1752–1758. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Rahmati R, Dogan S, Pyke O, Palmer F, Awad
M, Lee N, Kraus DH, Shah JP, Patel SG and Ganly I: Squamous cell
carcinoma of the tonsil managed by conventional surgery and
postoperative radiation. Head Neck. 37:800–807. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Reimers N, Kasper HU, Weissenborn SJ,
Stützer H, Preuss SF, Hoffmann TK, Speel EJ, Dienes HP, Pfister HJ,
Guntinas-Lichius O and Klussmann JP: Combined analysis of HPV-DNA,
p16 and EGFR expression to predict prognosis in oropharyngeal
cancer. Int J Cancer. 120:1731–1738. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Rietbergen MM, Brakenhoff RH, Bloemena E,
Witte BI, Snijders PJ, Heideman DA, Boon D, Koljenovic S,
Baatenburg-de Jong RJ and Leemans CR: Human papillomavirus
detection and comorbidity: critical issues in selection of patients
with oropharyngeal cancer for treatment De-escalation trials. Ann
Oncol. 24:2740–2745. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Rischin D, Young RJ, Fisher R, Fox SB, Le
QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, et al:
Prognostic significance of p16INK4A and human papillomavirus in
patients with oropharyngeal cancer treated on TROG 02.02 phase III
trial. J Clin Oncol. 28:4142–4148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Rodrigo JP, Heideman DA, García-Pedrero
JM, Fresno MF, Brakenhoff RH, Díaz Molina JP, Snijders PJ and
Hermsen MA: Time trends in the prevalence of HPV in oropharyngeal
squamous cell carcinomas in northern Spain (1990–2009). Int J
Cancer. 134:487–492. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Schache AG, Liloglou T, Risk JM, Liloglou
T, Risk JM, Filia A, Jones TM, Sheard J, Woolgar JA, Helliwell TR,
Triantafyllou A, Robinson M, Sloan P, et al: Evaluation of human
papilloma virus diagnostic testing in oropharyngeal squamous cell
carcinoma: sensitivity, specificity, and prognostic discrimination.
Clin Cancer Res. 17:6262–6271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sedaghat AR, Zhang Z, Begum S, Palermo R,
Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, et al:
Prognostic significance of human papillomavirus in oropharyngeal
squamous cell carcinomas. Laryngoscope. 119:1542–1549. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Semrau R, Duerbaum H, Temming S, Huebbers
C, Stenner M, Drebber U, Klussmann JP, Müller RP and Preuss SF:
Prognostic impact of human papillomavirus status, survivin, and
epidermal growth factor receptor expression on survival in patients
treated with radiochemotherapy for very advanced nonresectable
oropharyngeal cancer. Head Neck. 35:1339–1344. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Shi W, Kato H, Perez-Ordonez B, Pintilie
M, Huang S, Hui A, O'Sullivan B, Waldron J, Cummings B, Kim J, et
al: Comparative prognostic value of HPV16 E6 mRNA compared with in
situ hybridization for human oropharyngeal squamous carcinoma. J
Clin Oncol. 27:6213–6221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Song JS, Kim MS, Park JW, Lee YS and Kang
CS: Expression of human papillomavirus-related proteins and its
clinical implication in tonsillar squamous cell carcinoma. Korean J
Pathol. 46:177–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Song X, Sturgis EM, Huang Z, Li X, Li C,
Wei Q and Li G: Potentially functional variants of p14ARF are
associated with HPV-positive oropharyngeal cancer patients and
survival after definitive chemoradiotherapy. Carcinogenesis.
35:62–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Straetmans JM, Olthof N, Mooren JJ, de
Jong J, Speel EJ and Kremer B: Human papillomavirus reduces the
prognostic value of nodal involvement in tonsillar squamous cell
carcinomas. Laryngoscope. 119:1951–1957. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Tural D, Eliçin O, Batur S, Arslan D, Öz
B, Serdengeçti S and Uzel Ö: Human papillomavirus is independent
prognostic factor on outcome of oropharyngeal squamous cell
carcinoma. Tumour Biol. 34:3363–3369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Ukpo OC, Flanagan JJ, Ma XJ, Luo Y,
Thorstad WL and Lewis JS Jr: High-risk human papillomavirus E6/E7
mRNA detection by a novel in situ hybridization assay strongly
correlates with p16 expression and patient outcomes in
oropharyngeal squamous cell carcinoma. Am J Surg Pathol.
35:1343–1350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Ukpo OC, Pritchett CV, Lewis JE, Weaver
AL, Smith DI and Moore EJ: Human papillomavirus-associated
oropharyngeal squamous cell carcinomas: Primary tumor burden and
survival in surgical patients. Ann Otol Rhinol Laryngol.
118:368–373. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ward MJ, Mellows T, Harris S, Webb A,
Patel NN, Cox HJ, Piper K, Ottensmeier CH, Thomas GJ and King EV:
Staging and treatment of oropharyngeal cancer in the human
papillomavirus era. Head Neck. 37:1002–1013. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Ward MJ, Thirdborough SM, Mellows T, Riley
C, Harris S, Suchak K, Webb A, Hampton C, Patel NN, Randall CJ, et
al: Tumour-infiltrating lymphocytes predict for outcome in
HPV-positive oropharyngeal cancer. Br J Cancer. 110:489–500. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Weinberger PM, Merkley MA, Khichi SS, Lee
JR, Psyrri A, Jackson LL and Dynan WS: Human papillomavirus-active
head and neck cancer and ethnic health disparities. Laryngoscope.
120:1531–1537. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Weinberger PM, Yu Z, Haffty BG, Kowalski
D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, et
al: Molecular classification identifies a subset of human
papillomavirus-associated oropharyngeal cancers with favorable
prognosis. J Clin Oncol. 24:736–747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Worden FP, Kumar B, Lee JS, Wolf GT,
Cordell KG, Taylor JM, Urba SG, Eisbruch A, Teknos TN, Chepeha DB,
et al: Chemoselection as a strategy for organ preservation in
advanced oropharynx cancer: Response and survival positively
associated with HPV16 copy number. J Clin Oncol. 26:3138–3146.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Worsham MJ1, Stephen JK, Chen KM, Mahan M,
Schweitzer V, Havard S and Divine G: Improved survival with HPV
among African Americans with oropharyngeal cancer. Clin Cancer Res.
19:2486–2492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Young RJ, Rischin D, Fisher R, McArthur
GA, Fox SB, Peters LJ, Corry J, Lim A, Waldeck K and Solomon B:
Relationship between epidermal growth factor receptor status,
p16(INK4A), and outcome in head and neck squamous cell carcinoma.
Cancer Epidemiol Biomarkers Prev. 20:1230–1237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Chen YW, Kao SY and Yang MH: Analysis of
p16(INK4A) expression of oral squamous cell carcinomas in Taiwan:
Prognostic correlation without relevance to betel quid consumption.
J Surg Oncol. 106:149–154. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Duray A, Descamps G, Decaestecker C,
Remmelink M, Sirtaine N, Lechien J, Ernoux-Neufcoeur P, Bletard N,
Somja J, Depuydt CE, et al: Human papillomavirus DNA strongly
correlates with a poorer prognosis in oral cavity carcinoma.
Laryngoscope. 122:1558–1565. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Elango KJ, Suresh A, Erode EM,
Subhadradevi L, Ravindran HK, Iyer SK, Iyer SK and Kuriakose MA:
Role of human papilloma virus in oral tongue squamous cell
carcinoma. Asian Pac J Cancer Prev. 12:889–896. 2011.PubMed/NCBI
|
|
94
|
Gröbe A, Hanken H, Kluwe L, Schöllchen M,
Tribius S, Pohlenz P, Clauditz T, Grob T, Simon R, Sauter G,
Heiland M and Blessmann M: Immunohistochemical analysis of p16
expression, HPV infection and its prognostic utility in oral
squamous cell carcinoma. J Oral Pathol Med. 42:676–681. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Huang SF, Li HF, Liao CT, Wang HM, Chen
IH, Chang JT, Chen YJ and Cheng AJ: Association of HPV infections
with second primary tumors in early-staged oral cavity cancer. Oral
Dis. 18:809–815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Kozomara R, Jović N, Magić Z,
Branković-Magić M and Minić V: p53 mutations and human
papillomavirus infection in oral squamous cell carcinomas:
correlation with overall survival. J Craniomaxillofac Surg.
33:342–348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Kruger M, Pabst AM, Walter C, Sagheb K,
Günther C, Blatt S, Weise K, Al-Nawas B and Ziebart T: The
prevalence of human papilloma virus (HPV) infections in oral
squamous cell carcinomas: A retrospective analysis of 88 patients
and literature overview. J Craniomaxillofac Surg. 42:1506–1514.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Lee LA, Huang CG, Liao CT, Lee LY, Hsueh
C, Chen TC, Lin CY, Fan KH, Wang HM, Huang SF, et al: Human
papillomavirus-16 infection in advanced oral cavity cancer patients
is related to an increased risk of distant metastases and poor
survival. PLoS One. 7:e407672012. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lee LA, Huang CG, Tsao KC, Liao CT, Kang
CJ, Chang KP, Huang SF, Chen IH, Fang TJ, Li HY, Yang SL, et al:
Increasing rates of low-risk human papillomavirus infections in
patients with oral cavity squamous cell carcinoma: association with
clinical outcomes. J Clin Virol. 57:331–337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Na II, Kang HJ, Cho SY, Koh JS, Lee JK,
Lee BC, Lee GH, Lee YS, Yoo HJ, Ryoo BY, Yang SH and Shim YS: EGFR
mutations and human papillomavirus in squamous cell carcinoma of
tongue and tonsil. Eur J Cancer. 43:520–526. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Reuschenbach M, Kansy K, Garbe K,
Vinokurova S, Flechtenmacher C, Toth C, Prigge ES, Thiele OC,
Reinert S, Hoffmann J, et al: Lack of evidence of human
papillomavirus-induced squamous cell carcinomas of the oral cavity
in southern Germany. Oral Oncol. 49:937–942. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Sugiyama M, Bhawal UK, Kawamura M, Ishioka
Y, Shigeishi H, Higashikawa K and Kamata N: Human papillomavirus-16
in oral squamous cell carcinoma: Clinical correlates and 5-year
survival. Br J Oral Maxillofac Surg. 45:116–122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zhao D, Xu QG, Chen XM and Fan MW: Human
papillomavirus as an independent predictor in oral squamous cell
cancer. Int J Oral Sci. 1:119–125. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Ankola AA, Smith RV, Burk RD, Prystowsky
MB, Sarta C and Schlecht NF: Comorbidity, human papillomavirus
infection and head and neck cancer survival in an ethnically
diverse population. Oral Oncol. 49:911–917. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Annertz K, Rosenquist K, Andersson G,
Jacobsson H, Hansson BG and Wennerberg J: High-risk HPV and
survival in patients with oral and oropharyngeal squamous cell
carcinoma - 5-year follow up of a population-based study. Acta
Otolaryngol. 134:843–851. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Badaracco G, Rizzo C, Mafera B, Pichi B,
Giannarelli D, Rahimi SS, Vigili MG and Venuti A: Molecular
analyses and prognostic relevance of HPV in head and neck tumours.
Oncol Rep. 17:931–939. 2007.PubMed/NCBI
|
|
107
|
Báez A, Almodóvar JI, Cantor A, Celestin
F, Cruz-Cruz L, Fonseca S, Trinidad-Pinedo J and Vega W: High
frequency of HPV16-associated head and neck squamous cell carcinoma
in the Puerto Rican population. Head Neck. 26:778–784. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Deng Z, Hasegawa M, Aoki K, Matayoshi S,
Kiyuna A, Yamashita Y, Uehara T, Agena S, Maeda H, Xie M, et al: A
comprehensive evaluation of human papillomavirus positive status
and p16INK4a overexpression as a prognostic biomarker in head and
neck squamous cell carcinoma. Int J Oncol. 45:67–76. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Deng Z, Hasegawa M, Yamashita Y, Matayoshi
S, Kiyuna A, Agena S, Uehara T, Maeda H and Suzuki M: Prognostic
value of human papillomavirus and squamous cell carcinoma antigen
in head and neck squamous cell carcinoma. Cancer Sci.
103:2127–2134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Duray A, Descamps G, Decaestecker C,
Sirtaine N, Gilles A, Khalifé M, Chantrain G, Depuydt CE, Delvenne
P and Saussez S: Human papillomavirus predicts the outcome
following concomitant chemoradiotherapy in patients with head and
neck squamous cell carcinomas. Oncol Rep. 30:371–376. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Fischer CA, Zlobec I, Green E, Probst S,
Storck C, Lugli A, Tornillo L, Wolfensberger M and Terracciano LM:
Is the improved prognosis of p16 positive oropharyngeal squamous
cell carcinoma dependent of the treatment modality? Int J Cancer.
126:1256–1262. 2010.PubMed/NCBI
|
|
112
|
Gavid M, Pillet S, Pozzetto B, Oriol M,
Dumollard JM, Timoshenko AP, Martin C and Prades JM: Human
papillomavirus and head and neck squamous cell carcinomas in the
South-East of France: Prevalence, viral expression, and prognostic
implications. Acta Otolaryngol. 133:538–543. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Hoffmann M, Görögh T, Gottschlich S,
Lohrey C, Rittgen W, Ambrosch P, Schwarz E and Kahn T: Human
papillomaviruses in head and neck cancer: 8 year-survival-analysis
of 73 patients. Cancer Lett. 218:199–206. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Joo YH, Jung CK, Sun DI, Park JO, Cho KJ
and Kim MS: High-risk human papillomavirus and cervical lymph node
metastasis in patients with oropharyngeal cancer. Head Neck.
34:10–14. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Klozar J, Koslabova E, Kratochvil V,
Salakova M and Tachezy R: Nodal status is not a prognostic factor
in patients with HPV-positive oral/oropharyngeal tumors. J Surg
Oncol. 107:625–633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Klozar J, Kratochvil V, Salakova M,
Smahelova J, Vesela E, Hamsikova E, Betka J and Tachez R: HPV
status and regional metastasis in the prognosis of oral and
oropharyngeal cancer. Eur Arch Otorhinolaryngol. 265 Suppl
1:S75–S82. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Kong CS, Narasimhan B, Cao H, Kwok S,
Erickson JP, Koong A, Pourmand N and Le QT: The relationship
between human papillomavirus status and other molecular prognostic
markers in head and neck squamous cell carcinomas. Int J Radiat
Oncol Biol Phys. 74:553–561. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Laco J, Nekvindova J, Novakova V,
Celakovsky P, Dolezalova H, Tucek L, Vosmikova H, Vosmik M,
Neskudlova T, Cermakova E, et al: Biologic importance and
prognostic significance of selected clinicopathological parameters
in patients with oral and oropharyngeal squamous cell carcinoma,
with emphasis on smoking, protein p16(INK4a) expression, and HPV
status. Neoplasma. 59:398–408. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Lassen P, Eriksen JG, Krogdahl A,
Therkildsen MH, Ulhøi BP, Overgaard M, Specht L, Andersen E,
Johansen J, Andersen LJ, et al; Danish Head and Neck Cancer Group
(DAHANCA), . The influence of HPV-associated p16-expression on
accelerated fractionated radiotherapy in head and neck cancer:
Evaluation of the randomised DAHANCA 6&7 trial. Radiother
Oncol. 100:49–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
López RV, Levi JE, Eluf-Neto J, Koifman
RJ, Koifman S, Curado MP, Michaluart-Junior P, Figueiredo DL,
Saggioro FP, de Carvalho MB, et al: Human papillomavirus (HPV) 16
and the prognosis of head and neck cancer in a geographical region
with a low prevalence of HPV infection. Cancer Causes Control.
25:461–471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Lukesova E, Boucek J, Rotnaglova E,
Salakova M, Koslabova E, Grega M, Eckschlager T, Rihova B,
Prochazka B, Klozar J, et al: High level of Tregs is a positive
prognostic marker in patients with HPV-positive oral and
oropharyngeal squamous cell carcinomas. BioMed Res Int.
2014:3039292014. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Rades D, Seibold ND, Gebhard MP, Noack F,
Schild SE and Thorns C: Prognostic factors (including HPV status)
for irradiation of locally advanced squamous cell carcinoma of the
head and neck (SCCHN). Strahlenther Onkol. 187:626–632. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Rautava J, Kuuskoski J, Syrjanen K,
Grenman R and Syrjanen S: HPV genotypes and their prognostic
significance in head and neck squamous cell carcinomas. J Clin
Virol. 53:116–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Ritchie JM, Smith EM, Summersgill KF,
Hoffman HT, Wang D, Klussmann JP, Turek LP and Haugen TH: Human
papillomavirus infection as a prognostic factor in carcinomas of
the oral cavity and oropharynx. Int J Cancer. 104:336–344. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Rittà M, De Andrea M, Mondini M, Mazibrada
J, Giordano C, Pecorari G, Garzaro M, Landolfo V, Schena M, Chiusa
L, et al: Cell cycle and viral and immunologic profiles of head and
neck squamous cell carcinoma as predictable variables of tumor
progression. Head Neck. 31:318–327. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Rosenquist K, Wennerberg J, Annertz K,
Schildt EB, Hansson BG, Bladström A and Andersson G: Recurrence in
patients with oral and oropharyngeal squamous cell carcinoma: Human
papillomavirus and other risk factors. Acta Otolaryngol.
127:980–987. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Salazar CR, Anayannis N, Smith RV, Wang Y,
Haigentz M Jr, Garg M, Schiff BA, Kawachi N, Elman J, Belbin TJ,
Prystowsky MB, Burk RD and Schlecht NF: Combined P16 and human
papillomavirus testing predicts head and neck cancer survival. Int
J Cancer. 135:2404–2412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Salazar CR, Smith RV, Garg MK, Haigentz M
Jr, Schiff BA, Kawachi N, Anayannis N, Belbin TJ, Prystowsky MB,
Burk RD, et al: Human papillomavirus-associated head and neck
squamous cell carcinoma survival: A comparison by tumor site and
initial treatment. Head Neck Pathol. 8:77–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Settle K, Posner MR, Schumaker LM, Tan M,
Suntharalingam M, Goloubeva O, Strome SE, Haddad RI, Patel SS,
Cambell EV III, et al: Racial survival disparity in head and neck
cancer results from low prevalence of human papillomavirus
infection in black oropharyngeal cancer patients. Cancer Prev Res
(Phila). 2:776–781. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Smith EM, Rubenstein LM, Haugen TH,
Pawlita M and Turek LP: Complex etiology underlies risk and
survival in head and neck cancer human papillomavirus, tobacco, and
alcohol: A case for multifactor disease. J Oncol. 2012:5718622012.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Smith EM, Rubenstein LM, Hoffman H, Haugen
TH and Turek LP: Human papillomavirus, p16 and p53 expression
associated with survival of head and neck cancer. Infect Agent
Cancer. 5:42010. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Smith EM, Wang D, Rubenstein LM, Morris
WA, Turek LP and Haugen TH: Association between p53 and human
papillomavirus in head and neck cancer survival. Cancer Epidemiol
Biomarkers Prev. 17:421–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Stephen JK, Divine G, Chen KM, Chitale D,
Havard S and Worsham MJ: Significance of p16 in Site-specific HPV
Positive and HPV Negative Head and Neck Squamous Cell Carcinoma.
Cancer Clin Oncol. 2:51–61. 2013.PubMed/NCBI
|
|
134
|
Thibaudeau E, Fortin B, Coutlée F,
Nguyen-Tan P, Weng X, Audet ML, Abboud O, Guertin L, Christopoulos
A, Tabet J, et al: HPV prevalence and prognostic value in a
prospective cohort of 255 patients with locally advanced HNSCC: A
single-centre experience. Int J Otolaryngol. 2013:4378152013.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Alos L, Moyano S, Nadal A, Alobid I,
Blanch JL, Ayala E, Lloveras B, Quint W, Cardesa A and Ordi J:
Human papillomaviruses are identified in a subgroup of sinonasal
squamous cell carcinomas with favorable outcome. Cancer.
115:2701–2709. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Ernoux-Neufcoeur P, Arafa M, Decaestecker
C, Duray A, Remmelink M, Leroy X, Herfs M, Somja J, Depuydt CE,
Delvenne P, et al: Combined analysis of HPV DNA, p16, p21 and p53
to predict prognosis in patients with stage IV hypopharyngeal
carcinoma. J Cancer Res Clin Oncol. 137:173–181. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Fakhry C, Westra WH, Li S, Cmelak A, Ridge
JA, Pinto H, Forastiere A and Gillison ML: Improved survival of
patients with human papillomavirus-positive head and neck squamous
cell carcinoma in a prospective clinical trial. J Natl Cancer Inst.
100:261–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Friedland P, Thomas A, Naran A, Amanuel B,
Grieu-Iacopetta F, Carrello A, Harnett G, Meyer C and Phillips M:
Human papillomavirus and gene mutations in head and neck squamous
carcinomas. ANZ J Surg. 82:362–366. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Heath S, Willis V, Allan K, Purdie K,
Harwood C, Shields P, Simcock R, Williams T and Gilbert DC:
Clinically significant human papilloma virus in squamous cell
carcinoma of the head and neck in UK practice. Clin Oncol (R Coll
Radiol). 24:e18–23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Joo YH, Lee YS, Cho KJ, Park JO, Nam IC,
Kim CS, Kim SY and Kim MS: Characteristics and prognostic
implications of high-risk HPV-associated hypopharyngeal cancers.
PLoS One. 8:e787182013. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Lassen P, Eriksen JG, Hamilton-Dutoit S,
Tramm T, Alsner J and Overgaard J: Effect of HPV-associated
p16INK4A expression on response to radiotherapy and survival in
squamous cell carcinoma of the head and neck. J Clin Oncol.
27:1992–1998. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Lau HY, Brar S, Klimowicz AC, Petrillo SK,
Hao D, Brockton NT, Kong CS, Lees-Miller SP and Magliocco AM:
Prognostic significance of p16 in locally advanced squamous cell
carcinoma of the head and neck treated with concurrent cisplatin
and radiotherapy. Head Neck. 33:251–256. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Rampias T, Pectasides E, Prasad M, Sasaki
C, Gouveris P, Dimou A, Kountourakis P, Perisanidis C, Burtness B,
Zaramboukas T, Rimm D, et al: Molecular profile of head and neck
squamous cell carcinomas bearing p16 high phenotype. Ann Oncol.
24:2124–2131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Sethi S, Ali-Fehmi R, Franceschi S,
Struijk L, van Doorn LJ, Quint W, Albashiti B, Ibrahim M and Kato
I: Characteristics and survival of head and neck cancer by HPV
status: a cancer registry-based study. Int J Cancer. 131:1179–1186.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Sivars L, Näsman A, Tertipis N, Vlastos A,
Ramqvist T, Dalianis T, Munck-Wikland E and Nordemar S: Human
papillomavirus and p53 expression in cancer of unknown primary in
the head and neck region in relation to clinical outcome. Cancer
Med. 3:376–384. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Śnietura M, Jaworska M, Pigłowski W,
Goraj-Zając A, Woźniak G and and Lange D: High-risk HPV DNA status
and p16 (INK4a) expression as prognostic markers in patients with
squamous cell cancer of oral cavity and oropharynx. Pol J Pathol.
61:133–139. 2010.PubMed/NCBI
|
|
147
|
Stephen JK, Chen KM, Shah V, Havard S, Lu
M, Schweitzer VP, Gardner G and Worsham MJ: Human papillomavirus
outcomes in an access-to-care laryngeal cancer cohort. Otolaryngol
Head Neck Surg. 146:730–738. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Tribius S, Hoffmann AS, Bastrop S, Görögh
T, Haag J, Röcken C, Clauditz T, Grob T, Wilczak W, Tennstedt P, et
al: HPV status in patients with head and neck of carcinoma of
unknown primary site: HPV, tobacco smoking, and outcome. Oral
Oncol. 48:1178–1184. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Weiss D, Koopmann M and Rudack C:
Prevalence and impact on clinicopathological characteristics of
human papillomavirus-16 DNA in cervical lymph node metastases of
head and neck squamous cell carcinoma. Head Neck. 33:856–862. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Kreimer AR, Clifford GM, Boyle P and
Franceschi S: Human papillomavirus types in head and neck squamous
cell carcinomas worldwide: A systematic review. Cancer Epidemiol
Biomarkers Prev. 14:467–475. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman
SM and Tsao AS: Meta-analysis of the impact of human papillomavirus
(HPV) on cancer risk and overall survival in head and neck squamous
cell carcinomas (HNSCC). Head Neck Oncol. 2:152010. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Ng M, Freeman MK, Fleming TD, Robinson M,
Dwyer-Lindgren L, Thomson B, Wollum A, Sanman E, Wulf S, Lopez AD,
et al: Smoking prevalence and cigarette consumption in 187
countries, 1980-2012. JAMA. 311:183–192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Adelstein DJ, Ridge JA, Gillison ML,
Chaturvedi AK, D'Souza G, Gravitt PE, Westra W, Psyrri A, Kast WM,
Koutsky LA, Giuliano A, et al: Head and neck squamous cell cancer
and the human papillomavirus: summary of a National Cancer
Institute State of the Science Meeting, November 9-10, 2008,
Washington, D.C. Head Neck. 31:1393–1422. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Ragin CC and Taioli E: Survival of
squamous cell carcinoma of the head and neck in relation to human
papillomavirus infection: review and meta-analysis. Int J Cancer.
121:1813–1820. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Götz C, Drecoll E, Straub M, Bissinger O,
Wolff KD and Kolk A: Impact of HPV infection on oral squamous cell
carcinoma. Oncotarget. 7:76704–76712. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Butz K, Geisen C, Ullmann A, Spitkovsky D
and Hoppe-Seyler F: Cellular responses of HPV-positive cancer cells
to genotoxic anti-cancer agents: repression of E6/E7-oncogene
expression and induction of apoptosis. International journal of
cancer. Journal international du cancer. 68:506–513. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Hafkamp HC, Speel EJ, Haesevoets A, et al:
A subset of head and neck squamous cell carcinomas exhibits
integration of HPV 16/18 DNA and overexpression of p16INK4A and p53
in the absence of mutations in p53 exons 5-8. International journal
of cancer. Journal international du cancer. 107:394–400. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Gillison ML, Koch WM, Capone RB, Spafford
M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et
al: Evidence for a causal association between human papillomavirus
and a subset of head and neck cancers. J Natl Cancer Inst.
92:709–720. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Ragin CC, Taioli E, Weissfeld JL, White
JS, Rossie KM, Modugno F and Gollin SM: 11q13 amplification status
and human papillomavirus in relation to p16 expression defines two
distinct etiologies of head and neck tumours. Br J Cancer.
95:1432–1438. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Hoffmann TK, Arsov C, Schirlau K, Bas M,
Friebe-Hoffmann U, Klussmann JP, Scheckenbach K, Balz V, Bier H and
Whiteside TL: T cells specific for HPV16 E7 epitopes in patients
with squamous cell carcinoma of the oropharynx. Int J Cancer.
118:1984–1991. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Chaturvedi AK: Epidemiology and clinical
aspects of HPV in head and neck cancers. Head Neck Pathol. 6 Suppl
1:S16–S24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
De Petrini M, Rittà M, Schena M, Chiusa L,
Campisi P, Giordano C, Landolfo V, Pecorari G and Landolfo S: Head
and neck squamous cell carcinoma: Role of the human papillomavirus
in tumour progression. New Microbiol. 29:25–33. 2006.PubMed/NCBI
|
|
163
|
Kumar B, Cordell KG, Lee JS, Worden FP,
Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, et al:
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as
indicators of response to therapy and survival in oropharyngeal
cancer. J Clin Oncol. 26:3128–3137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Mellin H, Friesland S, Lewensohn R,
Dalianis T and Munck-Wikland E: Human papillomavirus (HPV) DNA in
tonsillar cancer: clinical correlates, risk of relapse, and
survival. International journal of cancer. Int J Cancer.
89:300–304. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Schwartz SR, Yueh B, McDougall JK, Daling
JR and Schwartz SM: Human papillomavirus infection and survival in
oral squamous cell cancer: a population-based study.
Otolaryngology--head and neck surgery : official journal of
American Academy of Otolaryngology-. Head Neck Surg. 125:1–9. 2001.
View Article : Google Scholar
|
